Weight Loss, Blood Sugar and Blood Lipid Effects of Tetrahydrocannabivarin (THCV) Impregnated Mucoadhesive Strips

Summary

The goal of this clinical trial is to compare the efficacy of two different daily doses of tetrahydrocannabivarin impregnated mouth strips in healthy non-diabetic obese adults. The main questions to answer are: * Is the low dose treatment superior to placebo for losing weight, abdominal girth, cholesterol levels and blood glucose levels? * Is the low dose treatment superior to placebo for losing weight, abdominal girth, cholesterol levels and blood glucose levels? * Is one dose better than the other dose? Participants will take either the low dose, high dose or placebo dose daily for ninety days and have physical measurements and blood tests obtained at the beginning and the end of the study.

Timeline

Start

2022-01-04

Primary completion

2022-05-04

Completion

2022-05-04

Drugs

Indications